Leveraging the EHR to Promote Pharmacy Adoption of Dosing Best Practices and Reduce Parent Errors in Administering Pediatric Liquid Medications: A Health Literacy-Informed Approach
Overview
- Phase
- Not Applicable
- Intervention
- Pre-Implementation - Usual Care
- Conditions
- Medication Dosing Error
- Sponsor
- NYU Langone Health
- Enrollment
- 500
- Locations
- 6
- Primary Endpoint
- Pharmacy Provision of Optimal Dosing Tool
- Status
- Completed
- Last Updated
- 26 days ago
Overview
Brief Summary
The study objective is to assess the impact of an automated electronic health record (EHR)-based intervention that leverages e-prescriptions to support pharmacist adherence to recommended dispensing practices, with the goal of reducing parent dosing errors.
Specifically, the study aims are to: 1) Examine the efficacy of the EHR-based intervention in improving pharmacy dispensing practices, including a) adherence to mL-only dosing and b) provision of optimal dosing tools; 2) Examine the efficacy of the EHR-based intervention in reducing parent dosing errors. The study will also explore whether implementation of the EHR-based intervention will reduce disparities in dosing errors by parent health literacy and LEP, and explore the efficacy of the EHR-based intervention in reducing ADEs.
A pre-/post-implementation study will be performed with English- and Spanish-speaking parents of children prescribed oral liquid medications in the pediatric emergency room, outpatient general pediatric clinic, and pediatric subspecialty clinics of 2 New York City hospital systems (NYU Langone Health - Brooklyn and NYC Health+Hospitals - Bellevue Hospital). Prior to implementation, e-Rx's will be generated by the EHR in the usual fashion; after implementation, e-Rx's will be generated by the EHR with instructions to the dispensing pharmacy to: 1) keep the dosing instructions in mL-only, and 2) dispense a specific dosing tool based on the amount prescribed.
The proposed project is consistent with a growing national focus on promoting the adoption of evidence-based strategies to improve disease management that address the needs of those with low health literacy and LEP from groups like the Joint Commission and the AHRQ.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Caregiver/Child
- •English or Spanish-speaking
- •Parent or legal guardian of a child prescribed a liquid medicine in the NYU Langone Health - Brooklyn or Bellevue ED, general outpatient pediatric clinic, or specialty care clinics
- •18 years of age or older
- •Child ≤8y discharged home with a Rx for ≥1 daily liquid medication dose ≤10mL, for use as a chronic or short course (≤14 days) medication
- •Primary person who will administer child's medications
- •Access to a smartphone that can take photos and send/receive text messages
- •Willingness and ability to participate
- •Pharmacy staff
- •1\. Works at a pharmacy that dispensed index medicine to one of our study participants.
Exclusion Criteria
- •Caregiver/Child
- •Does not have a working phone number
- •Not able to return for in-person follow-up visit
- •Was told to stop medication by provider after doctor/ED visit
- •Parent no longer having index medication bottle
- •Uncorrected hearing impairment
- •Self-reported poor visual acuity
- •Pharmacy staff
- •1\. Staff with no responsibility in determining unit of measure to include on Rx's or type/capacity of the dosing tool to dispense for pediatric oral liquid medications.
Arms & Interventions
Pre-Implementation - Usual Care
In pre-implementation phase, patient e-Rxs will be generated by the EHR in the usual fashion.
Post-Implementation - EHR-Based Approach
Intervention: EHR-Based Approach
Outcomes
Primary Outcomes
Pharmacy Provision of Optimal Dosing Tool
Time Frame: Within 4 weeks of index visit (Visit 1)
Pharmacy Use of mL-only on Rx Label
Time Frame: Within 4 weeks of index visit (Visit 1)
Caregiver Large Dosing Error
Time Frame: Within 8 weeks of index visit (Visit 2)
Large dosing error will be defined as \>40% deviation from the prescribed dose
Caregiver Dosing Error
Time Frame: Within 8 weeks of index visit (Visit 2)
Dosing error will be defined as \>20% deviation from the prescribed dose